Literature DB >> 24660123

Does ethnicity play a role in the dosing of warfarin in Hawai'i?

Sydney Y Tatsuno1, Eric M Tatsuno1.   

Abstract

Warfarin is the most common anticoagulant prescribed and its metabolism has been linked to two specific genes, CYP2C9 and VKORC1. This study analyzed 113 patients from 4 different ethnic backgrounds (Asian, Native Hawaiian, Portuguese, and Caucasian) and investigated the association between the mean daily dose of warfarin and ethnicity. Caucasian patients required the highest mean daily dose of warfarin 4.4 mg/day while Asian patients required the lowest mean daily dose of warfarin 2.5 mg/day. Portuguese patients and Native Hawaiian patients required mean of 3.8 mg/day. All three groups required a significantly lower dose than Caucasians. When adjusted for weight in kilograms, Native Hawaiian patients required a dose of 4.3 × 10(-2) mg/kg, Portuguese 4.4 × 10(-2) mg/kg and Asians 4.0 × 10(-2) mg/kg. These three populations had similar mean milligrams/kilogram dose requirements while Caucasians required a significantly higher dose of 5.3 × 10(-2) mg/kg. This data suggests that ethnicity should be taken into consideration when dosing warfarin.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24660123      PMCID: PMC3962032     

Source DB:  PubMed          Journal:  Hawaii J Med Public Health        ISSN: 2165-8242


  18 in total

1.  Lower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards.

Authors:  A LLerena; P Dorado; F O'Kirwan; R Jepson; J Licinio; M-L Wong
Journal:  Pharmacogenomics J       Date:  2004       Impact factor: 3.550

2.  Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients.

Authors:  Taisei Mushiroda; Yozo Ohnishi; Susumu Saito; Atsushi Takahashi; Yuka Kikuchi; Shigeru Saito; Hideki Shimomura; Yasuhiko Wanibuchi; Takao Suzuki; Naoyuki Kamatani; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2006-01-24       Impact factor: 3.172

3.  Effects of CYP4F2 and GGCX genetic variants on maintenance warfarin dose in a multi-ethnic Asian population.

Authors:  S L Chan; B C Goh; K S Chia; B Chuah; A Wong; R Lim; S C Lee
Journal:  Thromb Haemost       Date:  2011-04-07       Impact factor: 5.249

4.  A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms.

Authors:  Michela Cini; Cristina Legnani; Benilde Cosmi; Giuliana Guazzaloca; Lelia Valdrè; Mirella Frascaro; Gualtiero Palareti
Journal:  Eur J Clin Pharmacol       Date:  2012-02-19       Impact factor: 2.953

5.  Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans.

Authors:  Larisa H Cavallari; Minoli Perera; Mia Wadelius; Panos Deloukas; Gelson Taube; Shitalben R Patel; Keston Aquino-Michaels; Marlos A G Viana; Nancy L Shapiro; Edith A Nutescu
Journal:  Pharmacogenet Genomics       Date:  2012-02       Impact factor: 2.089

6.  Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations.

Authors:  Gin Gin Gan; Maude E Phipps; Michael M T Lee; Liang S Lu; Rajallectchumy Y Subramaniam; Ping C Bee; Sean H Chang
Journal:  Ann Hematol       Date:  2010-11-26       Impact factor: 3.673

Review 7.  The pharmacogenetics of the response to warfarin in Chinese.

Authors:  May P S Lam; Bernard M Y Cheung
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

8.  Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population.

Authors:  Soo-Chin Lee; Swee-Siang Ng; Johannes Oldenburg; Pei-Yi Chong; Simone Rost; Jia-Yi Guo; Hui-Ling Yap; Sheila Clare Rankin; Hui-Boon Khor; Tiong-Cheng Yeo; Kheng-Siang Ng; Richie Soong; Boon-Cher Goh
Journal:  Clin Pharmacol Ther       Date:  2006-03       Impact factor: 6.875

9.  Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin.

Authors:  Cong Ma; Yuxiao Zhang; Qiang Xu; Jie Yang; Yan Zhang; Lei Gao; Bin Xu; Hongjuan Wang; Yang Li; Caiyi Lu; Tong Yin
Journal:  Int J Hematol       Date:  2012-10-27       Impact factor: 2.490

10.  Prediction of warfarin dose reductions in Puerto Rican patients, based on combinatorial CYP2C9 and VKORC1 genotypes.

Authors:  Isa Ivette Valentin; Joan Vazquez; Giselle Rivera-Miranda; Richard L Seip; Meredith Velez; Mohan Kocherla; Kali Bogaard; Iadelisse Cruz-Gonzalez; Carmen L Cadilla; Jessica Y Renta; Juan F Feliu; Alga S Ramos; Yirelia Alejandro-Cowan; Krystyna Gorowski; Gualberto Ruaño; Jorge Duconge
Journal:  Ann Pharmacother       Date:  2012-01-24       Impact factor: 3.154

View more
  1 in total

1.  Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical Trial.

Authors:  Chengxian Guo; Yun Kuang; Honghao Zhou; Hong Yuan; Qi Pei; Jingle Li; Weihong Jiang; Chee M Ng; Xiaoping Chen; Yong Huo; Yimin Cui; Xiaobin Wang; Jingjing Yu; Xue Sun; Wanying Yu; Peng Chen; Da Miao; Wenyu Liu; Zaixin Yu; Zewei Ouyang; Xiangjiang Shi; Chunmei Lv; Zijing Peng; Guozuo Xiong; Gaofeng Zeng; Jianping Zeng; Haiying Dai; Jianqiang Peng; Yuming Zhang; Fanghua Xu; Jie Wu; Xiaoliang Chen; Hao Gong; Zhiyuan Yang; Xianming Wu; Qiulian Fang; Liu Yang; Haigang Li; Hongyi Tan; Zhijun Huang; Xiaohong Tang; Qiong Yang; Shan Tu; Xiaoyan Wang; Yuxia Xiang; Jie Huang; Xiaomin Wang; Jingjing Cai; Shanjie Jiang; Lu Huang; Jinfu Peng; Liying Gong; Chan Zou; Guoping Yang
Journal:  Circ Genom Precis Med       Date:  2020-06-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.